Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 08:43 am Purchase | 2025-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Deep Track Capital, LP | 1,956,867 6.780% | 472,354![]() (+31.82%) | Filing History |
| 2026-02-05 2:48 pm Purchase | 2025-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 2,816,862 9.800% | 708,600![]() (+33.61%) | Filing History |
| 2026-01-20 4:42 pm Sale | 2025-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Integrated Core Strategies (US) LLC | 670,428 2.300% | -468,056![]() (-41.11%) | Filing History |
| 2025-11-13 4:29 pm Sale | 2025-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Integrated Core Strategies (US) LLC | 1,138,484 4.100% | -243,789![]() (-17.64%) | Filing History |
| 2025-11-07 12:10 pm Purchase | 2025-10-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | JANUS HENDERSON GROUP PLC JHG | 3,494,068 12.100% | 3,494,068![]() (New Position) | Filing History |
| 2025-10-09 4:52 pm Purchase | 2025-10-02 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Deep Track Capital, LP | 1,484,513 5.330% | 1,484,513![]() (New Position) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | BlackRock Inc. BLK | 1,673,483 7.800% | -261,228![]() (-13.50%) | Filing History |
| 2025-02-14 5:05 pm Purchase | 2025-02-12 | 13D | Enanta Pharmaceuticals, Inc. ENTA | Luly Jay R. | 1,703,616 7.700% | 337,298![]() (+24.69%) | Filing History |
| 2025-02-11 12:11 pm Purchase | 2024-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 2,108,262 9.900% | 83,262![]() (+4.11%) | Filing History |
| 2025-01-22 4:01 pm Purchase | 2025-01-14 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Integrated Core Strategies (US) LLC | 1,382,273 6.500% | 1,382,273![]() (New Position) | Filing History |
| 2024-11-14 4:03 pm Sale | 2024-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Armistice Capital, LLC | 1,000,000 4.720% | -1,064,000![]() (-51.55%) | Filing History |
| 2024-10-17 4:31 pm Sale | 2024-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Millennium Management LLC | 731,295 3.500% | -583,654![]() (-44.39%) | Filing History |
| 2024-02-27 1:11 pm Purchase | 2024-02-22 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Krensavage Asset Management LLC | 1,086,024 5.100% | 1,086,024![]() (New Position) | Filing History |
| 2024-02-14 2:26 pm Sale | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Armistice Capital, LLC | 2,064,000 9.800% | -14,000![]() (-0.67%) | Filing History |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | Enanta Pharmaceuticals, Inc. ENTA | The Vanguard Group | 1,793,786 8.520% | 271,597![]() (+17.84%) | Filing History |
| 2024-01-26 09:11 am Purchase | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 2,025,000 9.600% | 475,000![]() (+30.65%) | Filing History |
| 2024-01-24 5:23 pm Sale | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | BlackRock Inc. BLK | 1,934,711 9.200% | -43,300![]() (-2.19%) | Filing History |
| 2024-01-22 12:25 pm Sale | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 425,640 2.020% | -1,086,552![]() (-71.85%) | Filing History |
| 2024-01-11 4:15 pm Purchase | 2024-01-05 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Millennium Management LLC | 1,314,949 6.200% | 290,273![]() (+28.33%) | Filing History |
| 2023-11-16 4:31 pm Purchase | 2023-11-07 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Millennium Management LLC | 1,024,676 4.900% | 1,024,676![]() (New Position) | Filing History |

